CIK 0001787306
- Large accelerated filer
Arcutis Biotherapeutics, Inc.
Sign in to watch- Ticker
- ARQT
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 812974255
- Phone
- +1 805-418-5006
- Business address
- 3027 TOWNSGATE ROAD, SUITE 300, WESTLAKE VILLAGE, CA, 91361
- Former names
- Arcutis, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $3,253,826
- in 9 filings, $2.1M under 10b5-1 plans
Net −$3,253,826. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-05-31 | Leonard Keith R Director | Grant or award · Stock Option (right to buy) | +12,220 | 12,220 | ||
| 2023-05-31 | Krishnamohan Neha Director | Grant or award | +4,375 | 5,607 | ||
| 2023-05-31 | Krishnamohan Neha Director | Grant or award · Stock Option (right to buy) | +12,220 | 12,220 | ||
| 2023-05-31 | Welgus Howard G. Director | Grant or award | +4,375 | 170,200 | ||
| 2023-05-31 | Welgus Howard G. Director | Grant or award · Stock Option (right to buy) | +12,220 | 12,220 | ||
| 2023-05-27 | Matsuda Masaru | Grant or award | +4,875 | 43,976 | ||
| 2023-04-17 | Welgus Howard G. Director | Exercise or conversion 10b5-1 | +8,500 | $1.68 | $14K | 174,325 |
| 2023-04-17 | Welgus Howard G. Director | Sale 10b5-1 | −8,500 | $13.97 | $119K | 165,825 |
| 2023-04-17 | Welgus Howard G. Director | Exercise or conversion · Stock Option (right to buy) 10b5-1 | −8,500 | 6,458 | ||
| 2023-04-06 | Welgus Howard G. Director | Exercise or conversion 10b5-1 | +8,500 | $1.68 | $14K | 174,325 |
| 2023-04-06 | Welgus Howard G. Director | Sale 10b5-1 | −8,500 | $12.01 | $102K | 165,825 |
| 2023-04-06 | Welgus Howard G. Director | Exercise or conversion · Stock Option (right to buy) 10b5-1 | −8,500 | 14,958 | ||
| 2023-03-06 | Watanabe Todd Franklin Director | Sale | −2,435 | $15.26 | $37K | 366,657 |
| 2023-03-06 | Burrows Scott L Chief Financial Officer | Sale | −291 | $15.26 | $4K | 59,115 |
| 2023-03-06 | Burnett Patrick | Sale | −851 | $15.26 | $13K | 59,962 |
| 2023-03-06 | Turney Patricia A. SVP, Operations | Sale | −831 | $15.26 | $13K | 62,862 |
| 2023-03-06 | OSBORNE DAVID W Chief Technical Officer | Sale | −690 | $15.26 | $11K | 268,854 |
| 2023-03-06 | Lock Kenneth A. Chief Commercial Officer | Sale | −831 | $15.26 | $13K | 63,429 |
| 2023-03-02 | Watanabe Todd Franklin Director | Grant or award | +87,500 | 456,592 | ||
| 2023-03-02 | Watanabe Todd Franklin Director | Grant or award · Stock Option (right to buy) | +232,000 | 232,000 |
Page 24 of 35 · 689 trades